Greenberg Traurig LLP counsels innovative life sciences companies in the biotech, pharma, medical devices, and healthcare sectors. It handles regulatory and transactional matters, while being particularly strong in IP. The team advises on IP portfolio management and diligence, litigation, and sale internationally, with ‘excellent knowledge’ across jurisdictions. The practice is co-headed by Boston-based patent attorney David Dykeman, focused on securing worldwide IP protection, and Atlanta’s Wayne Elowe, who concentrates on worldwide corporate counseling and complex commercial transactions, such as M&A, licensing and joint ventures. Melissa Hunter-Ensor, in Boston, experienced in IP portfolio management, strategic alliances, and litigation strategy, is a key figure in the practice. Chia-Feng Lu, based in Washington DC and Tokyo, applies his ’strategic thinking’ to regulatory and transactional law.
Legal 500 redaktioneller Kommentar
Auszeichnungen
Mandantenzufriedenheit: Qualität von AnwältInnen & Team
Mandantenzufriedenheit: Abrechnung & Effizienz
Anwält*innen
Leading partners
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Next Generation Partners
Juniorpartner*innen, die im Markt von Mandanten und Wettbewerbern anerkannt werden und in einigen Mandaten eine Schlüsselrolle einnehmen.
Chia-Feng Lu
Praxisleitung
David Dykeman; Wayne Elowe
Weitere Kernanwält*innen
Lori Cohen; Melissa Hunter-Ensor; Jonathan Ball; Chia-Feng Lu; David Harburger; Prashant Girinath; Jeffrey C. Giering; Micheal Hebert; Roman Fayerberg
